Light may replace needle for breast cancer diagnosis

NCT ID NCT06857669

Recruiting now Diagnosis Sponsor: Region Skane Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether special light-based scans (photoacoustic imaging and diffuse reflectance spectroscopy) can tell the difference between healthy, benign, and malignant breast tissue. Researchers will scan 90 women with known breast lumps and compare the scan results to standard tissue analysis. If the optical technique works, it could offer a faster, painless way to diagnose breast cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Diffuse reflectance spectroscopy and photoacoustic imaging
What this could lead to: If successful, this could lead to a non-invasive, radiation-free way to diagnose breast cancer, reducing the need for biopsies.
What could go wrong: This is an early-stage diagnostic study with only 90 participants. The technique may not be accurate enough to replace standard biopsy, and results may not apply to all breast types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN BREAST TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast benign neoplasm breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENIGN BREAST TUMORS HEALTHY MALIGNANT BREAST TUMOURS

Contacts and locations

Locations

Skane University Hospital
RECRUITING

Malmö, 20502, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.